Turnstone Biologics (Nasdaq: TSBX) is restructuring operations, cutting 60% of its workforce to focus on its lead program, ...

The Danish Medicines Council forecasts processing times for treatment evaluations will rise from 19 to 27 weeks by Q1 2025 ...

The FDA has approved new 2mL pre-filled syringes and autoinjectors for UCB's Bimzelx (bimekizumab-bkzx) to treat psoriasis. Each contains 320mg, offering single-injection options alongside existing ...

Shares of French biotech Transgene (tumbled 13.5% to 1.01 euros by late morning after it announced that its randomized Phase ...

The South African Health Products Regulatory Authority (SAHPRA) and the Australian Therapeutic Goods Administration (TGA) ...

Guangzhou, China-based Bio-Thera Solutions , a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer ...

Significant research news last week saw US biotech Scholar Rock release positive new data for its spinal atrophy (SMA) ...

The US Food and Drug Administration (FDA) on Friday approved US pharma giant Pfizer’s Hympavzi (marstacimab-hncq) for routine ...

California-based AI firm Suki has raised $70 million in new funding, led by Hedosophia, bringing its total to $165 million.

Switzerland-based KeyBioscience and US pharma major Eli Lilly have extended their collaboration on dual amylin calcitonin ...

Pfizer is set to present initial findings from its CULTIVATE study of Velsipity (etrasimod) in Crohn’s disease (CD) at UEG ...